Neuroxon-Pfs Injection

Neuroxon-Pfs Injection contains Citicoline injection 250 mg/mL (1 mL prefilled syringe). Prescription required.

Management of acute ischemic stroke (adjunct), traumatic brain injury, cognitive impairment/dementia-related symptoms and other neurodegenerative/neurological conditions as prescribed

Citicoline (CDP-choline) is a precursor of phosphatidylcholine and supports neuronal membrane phospholipid synthesis. It may enhance acetylcholine and dopamine neurotransmission and helps reduce neuronal damage during cerebral ischemia or injury.

For IV or IM use only as directed by a doctor. Administer the prescribed dose at recommended intervals; in hospital/clinical setting. Do not self-inject unless specifically trained; check solution for particles/discoloration before use.

Headache,dizziness,insomnia,nausea,diarrhea,flushing,changes in blood pressure,restlessness,injection site pain or redness

Use with caution in patients with severe vagotonia, history of seizures, or hypersensitivity to citicoline. Monitor blood pressure and neurological status as advised. Use only under medical supervision; avoid driving if dizziness occurs. Seek urgent care for signs of allergic reaction (rash, swelling, breathing difficulty).

Levodopa (may enhance effects),meclofenoxate/centrophenoxine (avoid duplicate choline-like therapy),other CNS stimulants (additive effects possible)

Store below 25°C, protect from light. Do not freeze. Keep in original pack; discard if solution is cloudy or contains particles. Keep out of reach of children.

Somazina 250 mg Injection,Strocit 250 mg Injection,Citicoline 250 mg Injection (generic),Ceraxon 250 mg Injection,Cognicol 250 mg Injection